OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
Jens Ingwersen, Lars Masanneck, Marc Pawlitzki, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Jens Ingwersen, Lars Masanneck, Marc Pawlitzki, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases
Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos
The Lancet Neurology (2024) Vol. 23, Iss. 6, pp. 615-624
Open Access | Times Cited: 19
Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos
The Lancet Neurology (2024) Vol. 23, Iss. 6, pp. 615-624
Open Access | Times Cited: 19
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Alise Carlson, Moein Amin, Jeffrey A. Cohen
Drugs (2024) Vol. 84, Iss. 3, pp. 285-304
Open Access | Times Cited: 16
Alise Carlson, Moein Amin, Jeffrey A. Cohen
Drugs (2024) Vol. 84, Iss. 3, pp. 285-304
Open Access | Times Cited: 16
Real-world evidence of ocrelizumab in Chilean patients with multiple sclerosis
Adolfo del Canto, Claudia Cárcamo, Lorena García, et al.
Multiple Sclerosis Journal (2025)
Closed Access | Times Cited: 1
Adolfo del Canto, Claudia Cárcamo, Lorena García, et al.
Multiple Sclerosis Journal (2025)
Closed Access | Times Cited: 1
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis
Pascal Benkert, Aleksandra Maceski, Sabine Schaedelin, et al.
Annals of Neurology (2024)
Open Access | Times Cited: 5
Pascal Benkert, Aleksandra Maceski, Sabine Schaedelin, et al.
Annals of Neurology (2024)
Open Access | Times Cited: 5
Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab
Lisa Revie, Annika Jürjens, Maria Eveslage, et al.
Multiple Sclerosis Journal (2025)
Closed Access
Lisa Revie, Annika Jürjens, Maria Eveslage, et al.
Multiple Sclerosis Journal (2025)
Closed Access
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
Julia Krämer, Heinz Wiendl
Current Opinion in Neurology (2024) Vol. 37, Iss. 3, pp. 237-244
Closed Access | Times Cited: 3
Julia Krämer, Heinz Wiendl
Current Opinion in Neurology (2024) Vol. 37, Iss. 3, pp. 237-244
Closed Access | Times Cited: 3
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world context
Luca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 10, pp. 1309-1321
Open Access | Times Cited: 3
Luca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 10, pp. 1309-1321
Open Access | Times Cited: 3
Homonymous Hemiatrophy of Macular Ganglion Cell Layer as a Marker of Retrograde Neurodegeneration in Multiple Sclerosis—A Narrative Review
Larisa Cujbă, Ana Banc, Tudor Drugan, et al.
Diagnostics (2024) Vol. 14, Iss. 12, pp. 1255-1255
Open Access | Times Cited: 1
Larisa Cujbă, Ana Banc, Tudor Drugan, et al.
Diagnostics (2024) Vol. 14, Iss. 12, pp. 1255-1255
Open Access | Times Cited: 1
The Faces of “Too Late”—A Surprisingly Progressive Cohort of “Stable” Relapsing Remitting Multiple Sclerosis Patients
Alin Ciubotaru, Cristina Grosu, Daniel Alexa, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1401-1401
Open Access | Times Cited: 1
Alin Ciubotaru, Cristina Grosu, Daniel Alexa, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1401-1401
Open Access | Times Cited: 1
Disability patterns in multiple sclerosis: a meta-analysis on PIRA and RAW in the real world context
Luca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Luca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis
Amanda Claudia Schuldesz, Ram Kiran Maganti, Raluca Tudor, et al.
Diseases (2024) Vol. 12, Iss. 6, pp. 127-127
Open Access
Amanda Claudia Schuldesz, Ram Kiran Maganti, Raluca Tudor, et al.
Diseases (2024) Vol. 12, Iss. 6, pp. 127-127
Open Access
Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
Fernando Rodríguez‐Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Fernando Rodríguez‐Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
